Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3914701rdf:typepubmed:Citationlld:pubmed
pubmed-article:3914701lifeskim:mentionsumls-concept:C0003873lld:lifeskim
pubmed-article:3914701lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:3914701lifeskim:mentionsumls-concept:C0020740lld:lifeskim
pubmed-article:3914701lifeskim:mentionsumls-concept:C0031990lld:lifeskim
pubmed-article:3914701lifeskim:mentionsumls-concept:C1579762lld:lifeskim
pubmed-article:3914701lifeskim:mentionsumls-concept:C0009491lld:lifeskim
pubmed-article:3914701pubmed:issue3 Suppl 1lld:pubmed
pubmed-article:3914701pubmed:dateCreated1986-6-9lld:pubmed
pubmed-article:3914701pubmed:abstractTextRecommended dosages of nonsteroidal anti-inflammatory drugs have increased considerably since their introduction. The maximum recommended dosage for ibuprofen, a widely prescribed drug for the treatment of rheumatoid arthritis, has increased from 400 mg three or four times a day (at the time of its introduction) to 2,400 mg per day at present. Piroxicam at 20 mg per day was compared with ibuprofen at 2,400 mg per day in 20 patients with rheumatoid arthritis. Both drugs were found to be effective, with similar side-effect profiles.lld:pubmed
pubmed-article:3914701pubmed:languageenglld:pubmed
pubmed-article:3914701pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3914701pubmed:citationSubsetIMlld:pubmed
pubmed-article:3914701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3914701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3914701pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3914701pubmed:statusMEDLINElld:pubmed
pubmed-article:3914701pubmed:monthFeblld:pubmed
pubmed-article:3914701pubmed:issn0049-0172lld:pubmed
pubmed-article:3914701pubmed:authorpubmed-author:McLaughlinG...lld:pubmed
pubmed-article:3914701pubmed:issnTypePrintlld:pubmed
pubmed-article:3914701pubmed:volume14lld:pubmed
pubmed-article:3914701pubmed:ownerNLMlld:pubmed
pubmed-article:3914701pubmed:authorsCompleteYlld:pubmed
pubmed-article:3914701pubmed:pagination11-3lld:pubmed
pubmed-article:3914701pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:meshHeadingpubmed-meshheading:3914701-...lld:pubmed
pubmed-article:3914701pubmed:year1985lld:pubmed
pubmed-article:3914701pubmed:articleTitleA double-blind comparative study of piroxicam and ibuprofen in the treatment of rheumatoid arthritis.lld:pubmed
pubmed-article:3914701pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3914701pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:3914701pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:3914701pubmed:publicationTypeControlled Clinical Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3914701lld:pubmed